treatment ( 1 ) relative competition of cpa with labelled dht in the tebg-binding capacity assay , ( 2 ) relative hypoestrogenism with this treatment , ( 3 ) a progestagen or even a partial agonistic androgen effect of cpa on tebg synthesis in the liver .
C0036883
tebg
C0023884
liver